Stockscreener 앱 받기
1.13
3.67%
0.04
시간 외 거래:
1.17
0.04
+3.54%
전일 마감가:
$1.09
열려 있는:
$1.08
하루 거래량:
89,253
Relative Volume:
0.63
시가총액:
$30.12M
수익:
$2,000
순이익/손실:
$-9.12M
주가수익비율:
-2.9026
EPS:
-0.3893
순현금흐름:
$-3.35M
1주 성능:
-2.59%
1개월 성능:
+41.27%
6개월 성능:
+4.63%
1년 성능:
-63.78%
1일 변동 폭
$1.0501
$1.16
1주일 범위
$1.0501
$1.2278
52주 변동 폭
$0.7069
$3.40
Abvc Biopharma Inc Stock (ABVC) Company Profile
명칭
Abvc Biopharma Inc
전화
510-668-0881
주소
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
1.13 | 30.12M | 2,000 | -9.12M | -3.35M | -0.3893 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abvc Biopharma Inc 주식(ABVC)의 최신 뉴스
Director stake could rise to about 18.86% if ABVC BioPharma (ABVC) OKs stock-for-land deal - Stock Titan
ABVC Q1 2025 Earnings: Net Loss of $0.06 Per Share as Clinical-Stage Pipeline AdvancesPre-Earnings Setup - dars.gov.et
ABVC BioPharma Completes BioKey Spin-Off, Distributing 15% Stake - Minichart
ABVC (ABVC) Financial Update: The Company Lists Its Latest Available Figures on the Day; Stock Move: Shares Finish 4.76% Lower in the Latest ReadingTangible Book Value - dars.gov.et
ABVC BioPharma (NASDAQ: ABVC) puts 6.6M-share land deal to a shareholder vote - Stock Titan
ABVC (ABVC) Today: Moves 1.11% Down to $0.89 in the Current Update; Trading Range: $0.85 and $0.93 Define the Nearby Reference Levels in the Latest SessionRetail Sentiment - vinanet.vn
ABVC BioPharma, Inc. completed the Spin-Off of BioKey, Inc. - marketscreener.com
ABVC (ABVC) Earnings Report: The Latest Financial Metrics Are Now Available in the Latest Session; Trading Response: Shares Finish 8.39% Up in the Latest SessionNet Income Trends - vinanet.vn
ABVC BioPharma (ABVC) Slides 5.56% to $0.85 as Micro-Cap Biotech Faces Selling PressureGap Fill Strategy - vinanet.vn
ABVC Q1 2025 Earnings: Net Loss of -$0.06 Per Share, Stock Slips 6.2%Earnings Growth Forecast - vinanet.vn
ABVC BioPharma (ABVC) Slips 6.2% to $0.90 as Selling Pressure Builds Near Key SupportInstitutional Buy Signals - vinanet.vn
ABVC BioPharma (ABVC) Declines 6.2% to $0.90, Testing Key SupportVolatility Smile - vinanet.vn
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
ABVC BioPharma (ABVC) plans new equity plan and up to 6.6M-share land deal - Stock Titan
ABVC BIOPHARMA, INC. Q2 2026: Revenue $0 EPS $(0.03) — 10-Q Summary - TradingView
ABVC BioPharma (ABVC) flags going concern risk after Q2 2026 cash drain - Stock Titan
ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21 - TradingView
Form 8K ABVC Biopharma Inc For: 12 August By Investing.com - Investing.com Nigeria
ABVC BioPharma (ABVC) Financials 2026Income Statement and Balance Sheet - MarketBeat
ABVC Q1 2025 Earnings: Reported -$0.06 EPS as Clinical-Stage Pipeline Continues Without RevenueEBITDA Estimate Trend - dars.gov.et
ABVC Biopharma Inc (ABVC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ABVC Q1 2025 Earnings: Net Loss of $0.06 Per Share as Clinical-Stage Biotech Remains Pre-RevenuePeak Earnings Alert - dars.gov.et
ABVC Biopharma Inc (ABVC) Stock News Today - TradingKey
ABVC BioPharma Delays Planned BioKey Share Distribution - TipRanks
ABVC postpones BioKey share distribution; ratio, record date unchanged - TradingView
ABVC BioPharma, Inc.Distribution Option Symbol: ABVC New Symbol: ABVC1 * * * Ex-Date Revised * * *moomoo - Moomoo
ABVC BioPharma (ABVC) Slips 6.48% to $1.01 as Stock Tests Key SupportWeekly Profile - dars.gov.et
ABVC BioPharma (ABVC) to vote on 2026 equity plan and Taiwan land-share issuance - Stock Titan
ABVC Biopharma Inc (ABVC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ABVC Biopharma Inc (ABVC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ABVC Biopharma Inc (ABVC) Cash Flow - TradingKey
ABVC Biopharma Inc (ABVC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ABVC Biopharma Inc (ABVC) Institutional Confidence - TradingKey
ABVC Biopharma Inc (ABVC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ABVC Biopharma Inc (ABVC) Balance Sheet - TradingKey
ABVC|ABVC Biopharma Inc|Price:1.030|Chg%:-0.120 - TradingKey
ABVC Biopharma Inc (ABVC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ABVC Biopharma Inc (ABVC) Valuation: PE, PB & Fair Value Analysis - TradingKey
ABVC Biopharma Inc (ABVC) Income Statement - TradingKey
ABVC BioPharma, Inc. Revenue Breakdown – NASDAQ:ABVC - TradingView
ABVC Q1 2025 Earnings: Loss Per Share of $0.06 as No Revenue Reported, Stock DeclinesEarnings Power Value - dars.gov.et
ABVC BioPharma Inc. (ABVC) Gains 3.3% as Shares Test Key ResistanceGEX Level - dars.gov.et
ABVC Q1 2025 Earnings: Net Loss Per Share of $0.06; Stock Declines on Thin TradingSlow Growth Warning - dars.gov.et
ABVC BioPharma Edges Lower, Trading Near Key Support at $1.27Price Gap Fill - vinanet.vn
MSN Money - MSN
ABVC BioPharma (ABVC) Rallies Over 6%, Testing Key Resistance at $2.12Volume Oscillator - dars.gov.et
ABVC BioPharma (ABVC) replaces auditor and reiterates going-concern language - Stock Titan
Price to sales forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
Enterprise value to EBITDA forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
Price to book forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
ABVC Should I Buy - Intellectia AI
Abvc Biopharma Inc (ABVC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):